Smart for Life to Participate in MicroCap Rodeo’s ‘Lassoing the Big Apple’ Conference May 16-17

Rhea-AI Summary

Smart for Life Announces Conference Participation

On April 24, 2023, Smart for Life, Inc. (Nasdaq: SMFL) revealed its invitation to present at the 'Lassoing the Big Apple' conference hosted by MicroCap Rodeo on May 16-17, 2023, at the New York Hilton Midtown. The event aims to enhance outreach activities to raise awareness of the company.

During the conference, management will conduct one-on-one meetings with qualified investors. Interested parties can request invitations or schedule meetings by contacting the company.

Smart for Life is focused on developing and marketing nutritional foods and supplements globally, targeting significant growth through its Buy-and-Build strategy, aiming to generate $300 million in revenues by Q4 2026. The company operates five subsidiaries and continues to expand its offerings.

Conference Represents Initiation of Enhanced Outreach Activities to Increase Awareness

MIAMI, April 24, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has been invited to present at MicroCap Rodeo’s ‘Lassoing the Big Apple’ conference, which is being held on May 16-17, 2023, at the New York Hilton Midtown.

Management will also host one-on-one meetings with qualified investors throughout the conference. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email smfl@crescendo-ir.com.

About Smart for Life, Inc.

Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at:
www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman. That report can be accessed here:
https://smartforlifecorp.com/2023/04/02/chairmans-video-report/.

Investor material and a Fact Sheet with additional information about Smart for Life is available at:
www.smartforlifecorp.com/investor-center.

Forward-Looking Statements

This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact

Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com 

FAQ

What is Smart for Life's upcoming conference event?

Smart for Life will present at the 'Lassoing the Big Apple' conference on May 16-17, 2023.

How can investors meet Smart for Life's management during the conference?

Investors can schedule one-on-one meetings with management during the conference by emailing the company.

What are Smart for Life’s growth targets for 2026?

Smart for Life aims to achieve $300 million in revenues by the fourth quarter of 2026.

What does Smart for Life focus on in its business operations?

Smart for Life focuses on the development, marketing, and manufacturing of nutritional foods and supplements.

Where will the 'Lassoing the Big Apple' conference take place?

The conference will take place at the New York Hilton Midtown.